Extreme caution must be advised for the use of SGLT2 in patients with pre-existing polyuria, polydipsia and/or salt wasting phenotypes of kidney disease such as renal hypoplasia, dysplasia or posterior urethral valves which are common causes of pediatric chronic kidney disease. Here, SLC5A2 is linked to chronic kidney disease.